SCHEMBL288301

SCHEMBL288301

CN(C)C(=O)c1ccc2c(n1)CCN2C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.38
CNR2 P34972 1/20 0.37
ALDH1A1 P00352 2/20 0.34
USP30 Q70CQ3 1/20 0.34
PIK3CB P42338 1/20 0.32
RIPK1 Q13546 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
IDO1 P14902 4/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
OGA O60502 1/20 0.31
KCNH2 Q12809 1/20 0.31
NOTUM Q6P988 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133297 0.83 KDM4E (0.38) ALDH1A1USP30LMNAGAATSHR
SCHEMBL288294 0.80 IDO1 (0.37) ALDH1A1USP30IDO1KCNH2NOTUM
SCHEMBL4201295 0.76 KDM4A (0.37) KDM4ACNR2ALDH1A1PIK3CBRIPK1
SCHEMBL22397743 0.75 NOTUM (0.38) ALDH1A1TSHRNPSR1IDO1KCNH2
SCHEMBL22158281 0.74 IDO1 (0.43) USP30IDO1KCNH2
SCHEMBL288069 0.66 AKT1 (0.44) ALDH1A1LMNATSHRNOTUMMEN1
SCHEMBL22397505 0.66 IDO1 (0.37) TSHRIDO1PDK1PDK2PDK3
SCHEMBL757919 0.66 KDM4A (0.38) KDM4ACNR2ALDH1A1PIK3CBOGA
SCHEMBL7941087 0.65 NOTUM (0.51) ALDH1A1NOTUM
SCHEMBL4209564 0.65 HTR2C (0.37) KDM4AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427450-A1 GPR 119 MODULATORS Pfizer Inc. (US) 2012-03-14 EP disclosed
EP-2427448-A1 Gpr 119 modulators Pfizer Inc. (US) 2012-03-14 EP disclosed
US-20120052130-A1 GPR 119 MODULATORS PFIZER INC. 2012-03-01 US disclosed
WO-2010128414-A1 GPR 119 MODULATORS PFIZER INC. (US) 2010-11-11 WO disclosed
WO-2010128425-A1 GPR 119 MODULATORS PFIZER INC. (US) 2010-11-11 WO disclosed
US-20100285145-A1 GPR 119 MODULATORS PFIZER INC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052130-A1 GPR 119 MODULATORS GPR119, GPR39, GPR65 KDM4A 4259/4885CNR2 199/4885ALDH1A1 1763/4885
US-20100285145-A1 GPR 119 MODULATORS GPR119, GPR65, GPR39 KDM4A 4302/4885CNR2 138/4885ALDH1A1 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.